Intrust Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.63M Sell
26,051
-446
-2% -$62.5K 0.3% 53
2025
Q4
$3.25M Buy
26,497
+219
+0.8% +$26.6K 0.27% 58
2025
Q3
$2.92M Sell
26,278
-466
-2% -$53K 0.24% 64
2025
Q2
$2.97M Buy
26,744
+41
+0.2% +$4.36K 0.26% 63
2025
Q1
$2.99M Sell
26,703
-61
-0.2% -$6.29K 0.3% 59
2024
Q4
$2.47M Buy
26,764
+2,435
+10% +$219K 0.25% 68
2024
Q3
$2.04M Buy
24,329
+1,624
+7% +$124K 0.2% 92
2024
Q2
$1.56M Sell
22,705
-3,575
-14% -$239K 0.17% 109
2024
Q1
$1.93M Buy
26,280
+815
+3% +$62.7K 0.21% 94
2023
Q4
$2.06M Buy
25,465
+2,133
+9% +$166K 0.24% 80
2023
Q3
$1.75M Sell
23,332
-1,276
-5% -$98.1K 0.22% 84
2023
Q2
$1.9M Sell
24,608
-2,232
-8% -$178K 0.23% 80
2023
Q1
$2.23M Sell
26,840
-1,578
-6% -$131K 0.29% 61
2022
Q4
$2.44M Sell
28,418
-1,159
-4% -$91.8K 0.34% 48
2022
Q3
$1.82M Buy
29,577
+2,857
+11% +$180K 0.28% 65
2022
Q2
$1.65M Buy
26,720
+3,779
+16% +$234K 0.24% 83
2022
Q1
$1.36M Buy
22,941
+766
+3% +$49K 0.17% 110
2021
Q4
$1.61M Buy
22,175
+238
+1% +$16.4K 0.19% 96
2021
Q3
$1.53M Buy
21,937
+2,287
+12% +$161K 0.2% 94
2021
Q2
$1.35M Buy
19,650
+2,214
+13% +$148K 0.18% 110
2021
Q1
$1.13M Buy
17,436
+70
+0.4% +$4.51K 0.16% 124
2020
Q4
$1.01M Sell
17,366
-4,611
-21% -$278K 0.15% 128
2020
Q3
$1.39M Sell
21,977
-3,797
-15% -$263K 0.25% 87
2020
Q2
$1.98M Sell
25,774
-3,405
-12% -$261K 0.39% 55
2020
Q1
$2.18M Buy
29,179
+9,446
+48% +$653K 0.61% 36
2019
Q4
$1.28M Sell
19,733
-1,330
-6% -$86.6K 0.29% 81
2019
Q3
$1.33M Buy
21,063
+1,384
+7% +$90.5K 0.33% 68
2019
Q2
$1.33M Buy
19,679
+3,780
+24% +$249K 0.32% 69
2019
Q1
$1.03M Buy
15,899
+49
+0.3% +$3.26K 0.26% 90
2018
Q4
$992K Sell
15,850
-4,082
-20% -$285K 0.29% 79
2018
Q3
$1.54M Sell
19,932
-395
-2% -$29.8K 0.39% 56
2018
Q2
$1.44M Buy
20,327
+1,849
+10% +$131K 0.4% 54
2018
Q1
$1.39M Buy
18,478
+875
+5% +$69.6K 0.4% 52
2017
Q4
$1.26M Buy
17,603
+221
+1% +$16.8K 0.38% 67
2017
Q3
$1.41M Buy
17,382
+2,755
+19% +$211K 0.46% 53
2017
Q2
$1.04M Buy
14,627
+450
+3% +$29.9K 0.35% 78
2017
Q1
$963K Buy
14,177
+464
+3% +$32.6K 0.34% 74
2016
Q4
$982K Sell
13,713
-98
-0.7% -$7.28K 0.37% 70
2016
Q3
$1.09M Sell
13,811
-1,002
-7% -$81.4K 0.44% 57
2016
Q2
$1.24M Buy
14,813
+2,475
+20% +$220K 0.5% 44
2016
Q1
$1.13M Sell
12,338
-6,732
-35% -$607K 0.41% 87
2015
Q4
$1.93M Sell
19,070
-288
-1% -$30K 0.72% 41
2015
Q3
$1.9M Buy
19,358
+272
+1% +$30.2K 0.72% 38
2015
Q2
$2.23M Buy
19,086
+424
+2% +$46.3K 0.78% 34
2015
Q1
$1.83M Buy
18,662
+1,184
+7% +$120K 0.65% 45
2014
Q4
$1.65M Sell
17,478
-1,355
-7% -$140K 0.61% 47
2014
Q3
$2M Sell
18,833
-1,100
-6% -$108K 0.78% 28
2014
Q2
$1.65M Sell
19,933
-670
-3% -$52.2K 0.62% 42
2014
Q1
$1.46M Buy
20,603
+3,938
+24% +$309K 0.6% 45
2013
Q4
$1.25M Buy
16,665
+545
+3% +$37.9K 0.54% 52
2013
Q3
$1.01M Buy
16,120
+1,486
+10% +$88.8K 0.49% 56
2013
Q2
$750K Buy
+14,634
New +$763K 0.33% 102

Other funds holding GILD

Intrust Bank's GILD Position: Q1 2026 in Review

Intrust Bank reduced its Gilead Sciences (GILD) stake by 1.7% in Q1 2026, selling an estimated $62.5K and leaving 26,051 shares worth $3.63M. The position accounts for 0.3% of the portfolio, ranked #53.

Intrust Bank first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Intrust Bank held 26,051 shares of Gilead Sciences worth $3.63M as of Q1 2026.
  • Intrust Bank sold 446 Gilead Sciences shares in Q1 2026, an estimated $62.5K.
  • Gilead Sciences made up 0.3% of Intrust Bank's portfolio in Q1 2026, its #53 holding.
  • Intrust Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Intrust Bank's 13F filing for Q1 2026, filed 6 May 2026.